- Cardiovascular of the DPP-4 inhibitors - Tessey Jose, Silvio Inzucchi, 2012
- Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus-induced diabetes mellitus and nephrotoxicity in a rat - American Journal of Transplantation
- DPP-4 inhibitor is safe in post-ACS patients with T2DM, even the high-risk period -
- DPP-4 - Mechanism Of Action YouTube
- Direct head‐to‐head comparison of glycaemic durability of dipeptidyl peptidase‐4 inhibitors and sulphonylureas in patients with type 2 diabetes mellitus: A meta‐analysis of long‐term randomized controlled trials - Chen - 2018 -
- Frontiers | Physiology Pharmacology of in Glucose Homeostasis and Treatment of Type 2 Diabetes
- DPP4 Inhibitor Screening Kit (Fluorometric) | K780 | BioVision,
- EFFEKTEN AF ET ELLER EN DPP-4 HæMMER På GLyKæMIEN
- Sitagliptin | ≥99%(HPLC) | | DPP
- Comparative Safety of Dipeptidyl Inhibitors Versus Sulfonylureas and Other Glucose-lowering for Three Acute Outcomes | Scientific
- Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Concomitant Antidiabetic Medications -
- of Inhibitors in Clinical Practice
- DPP4 Inhibitor Screening (Fluorometric) (ab284508) | Abcam
- Diabetes Drugs with Side Effect
- DPP4 Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained (Angiotensin-Converting Enzyme) Inhibitor Treatment |
- Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential from Natural Sources: A Novel Approach for the Diabetes
- Effects of DPP-4 inhibitor in the AD brain. During DPP-4 inhibitor... | Scientific Diagram
- peptidase-4 inhibitor - Wikipedia
- DPP-4 Inhibitor Januvia | Medicine
- dpp-4_inhibitors [TUSOM Pharmwiki]
- | Emerging of Dipeptidyl Peptidase-4 in Autoimmune Disease
- A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Myocarditis ScienceDirect
- DPP-4-hæmmer - Wikipedia, frie encyklopædi
- Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes Journal of Medicinal Chemistry
- Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 a retrospective cohort study - The Lancet Digital Health
- - First In Class DPP4 Inhibitor for Type 2 Diabetes by sunny Fang - Issuu